NCT06287762

A Natural History Study of RYR1-Related Disorders

RecruitingOBSERVATIONAL

Trial Details

Start: 2025-03-11Est. Completion: 2031-04-30

Enrollment target: 150 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Contact

Irene C Chrismer, R.N.irene.chrismer@nih.gov (240) 856-9808

Tokunbor A Lawal, C.R.N.P.lawalt@mail.nih.gov (301) 451-5951

Other microbiome trials you might be interested in

Dantrolene in Statin-induced MyopathyPhase 2Recruiting

Statins Induced Myopathy

Statins are one of the most efficient drugs for the treatment of hypercholesterolemia which is considered as one of the …

Multiple LocationsEst. completion Jan 2029

View Trial →

The Prevalence of RYR1-related DiseaseRecruiting

Neuromuscular DiseaseMalignant HyperthermiaCongenital MyopathyMultiminicore DiseaseNemaline MyopathyCentronuclear MyopathyCentral Core DiseaseCongenital Fiber Type Disproportion

The skeletal muscle ryanodine receptor (RYR1) gene encodes an important calcium channel in skeletal muscle, with an impo…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.